Results 271 to 280 of about 8,084,609 (393)

Development and full validation of a stability-indicating RP-LC method for the determination of anticancer drug Temozolomide in pharmaceutical form

, 2018
Evin Kapçak, Hayriye Eda Şatana Kara
openalex   +1 more source

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, Abderhmane Slioui, Angela Puma, Luisa Villa, Michele Cavalli, Andra Ezaru, Jérémy Garcia, Manuela Gambella, Federico Torre, Luca Jacopo Pavan, Nicolas Glaichenhaus, Sabrina Sacconi   +13 more
wiley   +1 more source

Biopolymer Casein-Pullulan Coating of Fe₃O₄ Nanocomposites for Xanthohumol Encapsulation and Delivery. [PDF]

Polymers (Basel)
Zahariev N, Penkov D, Boyuklieva R, Simeonov P, Lukova P, Ardasheva R, Katsarov P.   +6 more
europepmc   +1 more source

Relapsing–Remitting Multiple Sclerosis Is Associated With a Dysbiotic Oral Microbiome

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Multiple sclerosis (MS) is a chronic autoimmune disorder characterized by inflammation, demyelination, and neurological impairment. While the gut microbiota's role in MS is extensively studied, the association between the oral microbiota and MS remains underexplored, particularly in North American cohorts.
Sukirth M. Ganesan, Meeta Yadav, Sudeep Ghimire, Peter C. Lehman, Apurva J. Patel, Sydney Woods, Heena Olalde, Jemmie Hoang, Mishelle Paullus, Catherine Cherwin, Christine Gill, Tracey Cho, Ashutosh K. Mangalam   +12 more
wiley   +1 more source

Abnormal stability of dynamic functional architecture in drug‐naïve children with attention‐deficit/hyperactivity disorder [PDF]

Shuangli Chen, Beihui Xue, Ronghui Zhou, Andan Qian, Jiejie Tao, Chuang Yang, Xiaoqi Huang, Meihao Wang   +7 more
openalex   +1 more source

Engineered cysteine antibodies: an improved antibody-drug conjugate platform with a novel mechanism of drug-linker stability

Protein engineering, design & selection : PEDS, 2018
D. Sussman, Lori Westendorf, David W Meyer, C. Leiske, Martha E. Anderson, N. Okeley, Steve Alley, R. Lyon, R. Sanderson, Paul J. Carter, Dennis R. Benjamin   +10 more
semanticscholar   +1 more source

Decreased Serum 5‐HT: Clinical Correlates and Regulatory Role in NMJ of MG

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Although 5‐Hydroxytryptamine (5‐HT) indirectly stimulates muscle contraction and participates in regulating Acetylcholine receptor (AChR) cluster homeostasis in cellular, animal, and clinical studies, evidence regarding its potential to modulate muscle contraction in myasthenia gravis (MG) remains limited.
Xinru Shen, Jing Zhang, Xinyue Zhou, Xiaoxiao Yu, Haodong Shang, Shufan Chen, Lulu Zhen, Jinru Wu, Guanlian Hu, Xiaoyan Zhu, Zhan Sun, Yiren Wang, Jiahui Wang, Jie Lv, Xue Zhao, Yingna Zhang, Wei Guo, Ying Peng, Feng Gao   +18 more
wiley   +1 more source

Potent LeuBAT inhibitors designed in silico as next-generation duloxetine analogs for enhanced major depressive disorder treatment. [PDF]

Sci Rep
Yoosefian M, Bayramzadeh H, Abass KS, Mokhtari T.   +3 more
europepmc   +1 more source

Survey on Stability of Pharmaceutical Products in National List of Essential Drugs Used in Hospitals in Thailand

, 1999
C Rakwatin, D Nitysuddi, L Premjit, R Kovithvattanaphong, Yaowalak Wattanapisit, O Tanunkat   +5 more
openalex   +1 more source

Prediction of Stability of Drugs and Pharmaceutical Preparations

, 1962
Edward R. Garrett
openalex   +1 more source